,91 However, translating Bcl-xL inhibitors into the clinic is challenging: the BH3 mimetics analyzed thus far induce thrombocytopenia due to Bcl-xL’s role in maintaining platelet lifespan.117. Here, BCL2L1 is linked to Thrombocytopenia.